AZGP1 was proposed as a tumor suppressor in pancreatic cancer by Kong B. et al. Their study suggested that the AZGP1 gene induces mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-b-mediated ERK signaling [20]. This evidence concerns the gene TGFB1 and familial pancreatic carcinoma.